Oncogene - Table of Contents alert Volume 37 Issue 36

If you are unable to see the message below, click here to view.

Advertisement See how droplets are guiding precision medicine  Do you have the tools you need to support clinicians at decisive moments? Liquid biopsy promises a new level of precision in disease profiling and drug resistance monitoring. See how a promising new technology lets you use this method to its fullest potential to give clinicians insights that can guide personalized cancer treatments and save lives. TABLE OF CONTENTS Volume 37, Issue 36 In this issue Review Article Article Also new AOP Review Article Molecular alterations of cancer cell and tumour microenvironment in metastatic gastric cancer Weilin Li, Jennifer Mun-Kar Ng, Chi Chun Wong, Enders Kwok Wai Ng & Jun Yu Oncogene 2018 37 :4903 - 4920; May 23, 2018; 10.1038/s41388-018-0341-x Abstract | Full Text Article LOX-catalyzed collagen stabilization is a proximal cause for intrinsic resistance to chemotherapy Leonie Rossow, Simona Veitl, Sandra Vorlová, Jacqueline K. Wax, Anja E. Kuhn et al. Oncogene 2018 37 :4921 - 4940; May 21, 2018; 10.1038/s41388-018-0320-2 Abstract | Full Text Targeting the upstream transcriptional activator of PD-L1 as an alternative strategy in melanoma therapy Bo Zhu, Liming Tang, Shuyang Chen, Chengqian Yin, Shiguang Peng et al. Oncogene 2018 37 :4941 - 4954; May 22, 2018; 10.1038/s41388-018-0314-0 Abstract | Full Text Selective vulnerability of the primitive meningeal layer to prenatal Smo activation for skull base meningothelial meningioma formation Julien Boetto, Caroline Apra, Franck Bielle, Matthieu Peyre & Michel Kalamarides Oncogene 2018 37 :4955 - 4963; May 22, 2018; 10.1038/s41388-018-0328-7 Abstract | Full Text Tumor-derived exosomes promote tumor self-seeding in hepatocellular carcinoma by transferring miRNA-25-5p to enhance cell motility Hao Liu, Wei Chen, Xiao Zhi, En-Jiang Chen, Tao Wei et al. Oncogene 2018 37 :4964 - 4978; May 22, 2018; 10.1038/s41388-018-0309-x Abstract | Full Text Integration of Ca2+ signaling regulates the breast tumor cell response to simvastatin and doxorubicin Souleymane Abdoul-Azize, Catherine Buquet, Hong Li, Jean-Michel Picquenot & Jean-Pierre Vannier Oncogene 2018 37 :4979 - 4993; May 23, 2018; 10.1038/s41388-018-0329-6 Abstract | Full Text K6 linked polyubiquitylation of FADD by CHIP prevents death inducing signaling complex formation suppressing cell death Jinho Seo, Eun-Woo Lee, Jihye Shin, Daehyeon Seong, Young Woo Nam et al. Oncogene 2018 37 :4994 - 5006; May 23, 2018; 10.1038/s41388-018-0323-z Abstract | Full Text xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression Xiangming Ji, Jun Qian, S. M. Jamshedur Rahman, Peter J. Siska, Yong Zou et al. Oncogene 2018 37 :5007 - 5019; May 23, 2018; 10.1038/s41388-018-0307-z Abstract | Full Text Upregulation of the long noncoding RNA FOXD2-AS1 promotes carcinogenesis by epigenetically silencing EphB3 through EZH2 and LSD1, and predicts poor prognosis in gastric cancer Tong-peng Xu, Wen-yu Wang, Pei Ma, You Shuai, Kun Zhao et al. Oncogene 2018 37 :5020 - 5036; May 23, 2018; 10.1038/s41388-018-0308-y Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.